Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival. - Wikidata - awgldk - TriplyDB

Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.

Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.

http://www.wikidata.org/entity/Q38412375

about

Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma Biologic therapy in esophageal and gastric malignancies: current therapies and future directions HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions.A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas.Relative Prognostic Value of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Operable Oesophagogastric Cancer.Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.Expression levels of HER2 and MRP1 are not prognostic factors of long-term survival in 829 patients with esophageal squamous cell carcinoma Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma.HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation.Chimeric antigen receptor T cells: a novel therapy for solid tumors.Systematic review and meta-analysis of the influence of HER2 expression and amplification in operable oesophageal cancer.Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key?Treatment options for esophageal squamous cell carcinoma.Advances in biomarkers for esophageal cancer.The potential for targeting HER2 therapeutically in esophageal cancer - a grasp at straws?HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma.The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization study.Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications.Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer.Human epidermal growth factor receptor 2 overexpression and amplification in endoscopic biopsies and resection specimens in esophageal and junctional adenocarcinoma.Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis.Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis.Molecular Marker Expression Is Highly Heterogeneous in Esophageal Adenocarcinoma and Does Not Predict a Response to Neoadjuvant Therapy.

P2860

Q27026253-61B50350-C5D8-4EEC-A930-DFFBBC6B1CA5 Q27687612-2D678C45-4F28-48D5-A6BC-31A6975740EA Q28085367-F504C2D4-66C5-45B2-9946-E20EE0B383D7 Q33895597-99D66223-8ABB-4638-9E47-2D093D407464 Q34324291-85570209-6604-4FD3-A25C-516003A21C36 Q35218636-BD062854-49D0-4111-840C-DA41B6DDF500 Q35681702-BC017897-D9F5-41E9-B771-50504EAD4CD4 Q36140927-A85BE04F-DE27-4588-81D1-6839FC22DCAC Q36220464-D3B0D782-A219-47D2-97FC-10E8D6137AF1 Q36410392-52993BC1-7B6A-4860-889B-CC5DA544EFC2 Q36503276-5A25EE77-9F5C-42FA-93EB-42D070EA51AB Q36666667-F81A10F9-E893-45AA-B5B4-C6469D9F05EA Q37522215-A9660140-A26E-4369-98B6-44F2E4BD0944 Q37559084-7B50C48B-ED34-48CB-B121-85E2A975BE8B Q37728639-0081AEBD-BB1E-4BA7-A23B-E2AAA4D4ED0C Q38030442-DEA29D69-8F36-4E06-894F-541C0EE621F1 Q38031599-10BEEF16-F319-42EB-AC3F-78533462D795 Q38107007-B7FA37CD-D800-47DF-8AF5-2F4D45A8F253 Q38153443-2AB304C7-8AC5-4E71-95E0-FF346D391145 Q38254375-14AF73FE-5563-40A7-B421-B084E19CB372 Q41839228-F129A75A-A824-42B3-B954-3E18352D21E6 Q43500705-8B421F50-3F10-44A0-837E-52BCFF21E35E Q47561397-29831A87-C98C-4033-8304-59A048C7F6D6 Q47770012-3F3C1CAE-680F-4CD0-8DB5-AB9DD4CFBB28 Q51103473-11CB5894-9B10-4595-8531-71767104DE88 Q51121654-5EC70E46-64BB-430D-B746-DFAFD7E7A981 Q53128686-42B39AD2-BC9D-4D86-9106-B9CB1755CB1E Q53336630-75E6F530-EE0E-427B-87AD-4326A5221F9A

P2860

Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.

http://www.wikidata.org/entity/Q38412375

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.

@en

type

label

Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.

@en

prefLabel

Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.

@en

P1433

Q38412375-2401AED6-7329-4181-94B9-5635E5213BFE

P1476

Q38412375-AC5780D1-6794-4488-9014-27A1D0180833

P2093

Q38412375-10B32B66-8483-4220-AFE6-22E03D9225AE

Q38412375-6ECC90BC-C9B4-4E19-B602-87FB72412341

Q38412375-DB62B3E5-ABFB-4B9E-BC2E-F059345B3B83

P2860

Q38412375-016D54C7-FE07-4049-90F5-1BE071DB8F28

Q38412375-0BF8E417-4E48-406D-9CF5-F75B6CA31923

Q38412375-1A6A2AA3-307A-424D-9133-2FA0D02658A4

Q38412375-1BD727EF-AF40-438E-B184-F2BC3FA386BE

Q38412375-227006F7-09AE-46D1-A7D2-4476A3C7CD8D

Q38412375-2293F63F-C7F1-4792-8CCE-31A57EAA5199

Q38412375-24680519-2AE2-4710-BD35-3CE357E0B149

Q38412375-3C72A5A8-8AFF-4668-A769-EDAC2841C6F1

Q38412375-3D2A5B45-E6E0-49B9-AFE6-6EFD17D01D3E

Q38412375-5387D8CC-A900-43AC-9968-1CEFCDA88967

P2888

Q38412375-0D0F8EE3-5946-4FF6-BF8A-CD4D3E2FDACD

P304

Q38412375-AAF4755C-6A3A-4025-AB5D-4B7859B48427

P31

Q38412375-923B4C26-7F82-40CE-BD4C-38000241D818

P356

Q38412375-642BD94C-CC85-4D73-931C-C149CE65824F

P433

Q38412375-7B8BB3CD-3952-4627-831C-C05ABD3E3B92

P478

Q38412375-C3B5B846-9384-4FB3-AE20-607BF2D82984

P50

Q38412375-3167E377-1D0A-4E1C-9246-D08F953AAF33

P577

Q38412375-C65EED2A-073B-46CB-A0E1-71BFA4376A85

P5875

Q38412375-C8FA13F7-ECC0-40E6-B8A3-938F944E6BA4

P6179

Q38412375-1886E201-6CF2-4FEF-8BB7-CB2E2329B7A5

P698

Q38412375-98515A8C-6D6B-44AE-BE2A-E681A7CB7609

P921

Q38412375-F254160E-1665-4A76-BEB6-635B624E71FF

P356

S10434-011-1554-1

P1433

Annals of Surgical Oncology

P1476

Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival

@en

P2093

Andrew R Ruszkiewicz

http://www.w3.org/2001/XMLSchema#string

Ruth Davies

http://www.w3.org/2001/XMLSchema#string

Sarah K Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.

Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybrid

Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry

Cytokeratins and other sensitive markers for esophageal cancer and metastases.

A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies.

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

A study of HER2 gene amplification and protein expression in gastric cancer.

Emerging technologies for assessing HER2 amplification.

Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer.

P2888

s10434-011-1554-1

P304

2010-2017

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-011-1554-1

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Thomas R. Sullivan

P577

2011-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49786193

http://www.w3.org/2001/XMLSchema#string

P6179

1015754358

http://www.w3.org/2001/XMLSchema#string

P698

21267790

http://www.w3.org/2001/XMLSchema#string

P921